[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2014 Analysis of the US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices

November 2013 | 271 pages | ID: 266724B130EEN
Venture Planning Group

US$ 2,800.00 US$ 3,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 271-page report from Venture Planning Group provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.

During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

“2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

Contains 271 pages and 18 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Endocrine Function Tests
  1. Cortisol
  2. Estradiol
  3. Follicle-Stimulating Hormone (FSH)
  4. Gastrin
  5. Growth Hormone/IGF-1
  6. Human Chorionic Gonadotropin (HCG)
  7. LH
  8. Progesterone
  9. PTH/IO PTH
  10. Prolactin
  11. T3
  12. T3 Free
  13. T3 Uptake
  14. T4 (Thyroxine)
  15. T4 Free
  16. TBG
  17. Testosterone
  18. Thyroglobulin Ab
  19. TPO Ab
  20. TSH
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  3. Tandem Mass Spec
  4. IT and Automation
  5. Dry Chemistry
  6. Biosensors
D. Market Size, Growth and Major Supplier Shares

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott Laboratories
AdnaGen
Agilent Technologies
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio/Innogenetics
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

LIST OF TABLES

Major Companies Developing or Marketing FSH Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing LH Tests
Major Companies Developing or Marketing Prolactin Tests
Major Companies Developing or Marketing T3 Tests
Major Companies Developing or Marketing T4 Tests
Major Companies Developing or Marketing TSH Tests
U.S.A., Endocrine Function Test Volume Forecast By Market Segment
U.S.A., All Market Segments, Endocrine Function Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories, Endocrine Function Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices, Endocrine Function Test Volume Forecast by Assay
U.S.A., Endocrine Function Reagent Market Forecast By Market Segment
U.S.A., All Market Segments, Endocrine Function Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories, Endocrine Function Reagent Market Forecast by Assay
U.S.A., Physician Offices/Group Practices, Endocrine Function Reagent Market Forecast by Assay
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares


More Publications